Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06120257
Other study ID # KFSIRB200-69
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2022
Est. completion date September 1, 2022

Study information

Verified date December 2023
Source Kafrelsheikh University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study has been conducted in Urology department at Kafrelsheikh University Hospital between March 2022 to March 2023. informed consent was taken from eligible patients and were randomized into three groups, Group A :Flexible ureteroscope (F-URS) group underwent holmium laser lithotripsy using flexible ureteroscopy (Boston® scientific (lithovue) while, Group B : extracorporeal shock wave lithotripsy (ESWL) group underwent electromagnetic extracorporeal shock wave lithotripsy (STORZ® MEDICAL Modulith SLX-F2 FD21, Germany) .Group C : Mini perc group underwent holmium laser lithotripsy using Karl® Storz MIP set.


Recruitment information / eligibility

Status Completed
Enrollment 414
Est. completion date September 1, 2022
Est. primary completion date September 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patient older than 18 years. - single renal stone. - medium sized Stone up to 2.0 cm . - Do novo - Stone in lower calyceal stone - Hard stone Exclusion Criteria: - • multiple renal stones - stone size > 2 cm - age group < 18 - solitary kidney - Patients with BMI > 40 kg/m2 - bleeding disorders - anatomical renal abnormalities - Obstruction distal to the stone. - Musculoskeletal deformities

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
lithotripsy using Flexible ureteroscope
using Flexible ureteroscope and holmium laser lithotripsy to get high stone clearance rate
extracorporeal shock wave lithotripsy (ESWL)
using extracorporeal shock wave lithotripsy (ESWL) to get high stone clearance rate
holmium laser lithotripsy using Karl® Storz MIP set
using holmium laser lithotripsy using Karl® Storz MIP set to get high stone clearance rate

Locations

Country Name City State
Egypt Kafrelsheikh University hospital Kafr Ash Shaykh

Sponsors (1)

Lead Sponsor Collaborator
Elsayed Abdelhalim Elsayed

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary stone free rate no stone residual fragments or asymptomatic insignificant residual fragments less than or equal to 4 mm during patients follow up two weeks. after two weeks from primary procedure
Secondary assess operative time. assess operative time.in minutes during the procedure
Secondary visual analog scale Patient self dependent to assess degree of own pain, consists of a 10cm line, with two end points representing 0 minimum score('no pain') and 10 maximum score('pain as bad as it could possibly be').higher scores mean a worse outcome. immediately after the surgery
Secondary Radiation time Time of patient exposure for radiation in minutes during the procedure
Secondary Post operative complication Complication may occur post operative complication like fever, sever pain Up to 48 hours
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03924596 - Treatment of Renal Stones With Frankincense (Luban) Phase 1/Phase 2
Completed NCT03763539 - Ultraslow Full-power SWL Versus Slow Power-ramping SWL in Stones With High Attenuation Value N/A
Active, not recruiting NCT04578795 - Effectiveness of Single Use Flexible Ureteroscopes in Treatment of Renal Stones N/A
Recruiting NCT04367155 - Efficacy of Tranexamic Acid on Blood Loss During Percutaneous Nephrolithotomy. N/A
Completed NCT02658942 - Flexible Ureteroscopy Versus ESWL in the Management of Lower Calyceal Stones N/A
Completed NCT02645058 - RIRS Versus ESWL for the Treatment of Renal Stones N/A
Completed NCT02037906 - Escalating, Constant and Reduction Energy Output in SWL for Renal Stones N/A
Completed NCT05855057 - Effectiveness of US-Guided PCNL Different Positions in Renal Stones Treatment
Recruiting NCT03795532 - Ultraslow SWL Versus Slow SWL for Renal Stones With High Attenuation Value N/A
Completed NCT02373384 - The Predictors of Successful Oral Dissolution Therapy in Radiolucent Renal Stones; A Prospective Evaluation Phase 4
Completed NCT06175910 - Postoperative Outcomes of PCNL vs RIRS in Obese Patients With Pelvic 1.5:3 cm Renal Stones N/A
Completed NCT01619735 - "Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Completed NCT04345835 - Prone Flexed Position in Percutanous Nephrolithotomy N/A